Axxess Pharma Inc. Acquires Existing Revenues, Patents,
Formulations and NFL, NHL, UFC Athlete Endorsed Products From
Leading Canadian OTC Healthcare Company
Acquisition Includes Access to Over 20,000 Retailers and Global
Distribution Through Leading Global Specialty Health and Wellness
Retailer GNC
TORONTO, ON--(Marketwired - Sep 17, 2013) - Axxess Pharma Inc.
(PINKSHEETS: AXXE), a specialty pharmaceutical and nutritional
supplements company, today announced it has signed an Agreement for
its acquisition of the assets of Revive Bioscience Inc. a leading
Canadian OTC healthcare company, the terms of the deal remain
private.
Revive Bioscience Inc.'s assets include revenues, product
inventory, established sales channels, an attractive IP portfolio;
including a best-selling, OTC pain relief formula and a number of
other proprietary formulas.
Revive has a national distribution of products in Canada,
through GNC and independent retail stores, and expects to add other
large retail outlets later this year. The products Revive developed
will be sold in mass retail stores across Canada (currently in
market), USA and Mexico.
Further, the company has an exclusive world-wide license with
one of the top sporting brands in the world. This license provides
access to a global distribution network, including 20,000+
retailers. The branded products are endorsed by current athletes
from the NFL, NHL and UFC.
Revive also brings a number of key operators to Axxess Pharma
with extensive experience in retail and online sales. This will
benefit all of the products now controlled by Axxess Pharma.
Dr. Daniel Bagi, President of Axxess Pharma Inc., stated: "We
are extremely pleased and excited to announce this acquisition of
Revive. Both sides have been working long and hard to finalize this
acquisition, which will instantly add revenues to Axxess Pharma's
bottom line. We believe we can very quickly grow sales
significantly working with Revive's team through added marketing
efforts. They have great products which are widely recognized. We
expect this acquisition will facilitate access to capital and
enable a rapid ramp-up of sales for major revenue growth in the
near term."
For more information, please visit www.axxesspharmainc.com, or
contact Investor Relations at (973) 351-3868.
About Axxess Pharma Inc.:
Axxess Pharma Inc. is a Nevada Corporation operating through its
wholly-owned Canadian Subsidiary: Axxess Pharma Canada Inc.,
headquartered in Toronto. Axxess is a specialty Health Care
Products Company dedicated to improving health and quality of life
by offering select medicines, nutritional supplements and over the
counter remedies all across the Americas. Axxess's goal is to bring
additional products to the market and provide new, innovative
options for better health spanning areas such as high cholesterol,
blood pressure, acute pain, to optimal health management through
improved nutritional supplements.
Revive BioScience Inc.:
Revive BioScience Inc. is an international organization which
develops and markets medically proven, all-natural pain relief
products, including OTC analgesics, topical analgesics, supplements
and hot & cold therapy products. Revive's flagship product is
the patented all-natural topical pain relief formula, free of
chemical binders and additives, that absorbs quickly into the skin
providing fast, effective pain relief. Revive's patented formula
has 15 years of history, medical studies and numerous
endorsements.
GNC Holdings, Inc.:
GNC Holdings, Inc., headquartered in Pittsburgh, PA, is a
leading global specialty retailer of health and wellness products,
including vitamins, minerals, and herbal supplement products,
sports nutrition products and diet products, and trades on the New
York Stock Exchange under the symbol "GNC."
As of June 30, 2013, GNC has more than 8,300 locations, of which
more than 6,200 retail locations are in the United States
(including 969 franchise and 2,189 Rite Aid franchise
store-within-a-store locations) and franchise operations in 55
countries (including distribution centers where retail sales are
made). The Company -- which is dedicated to helping consumers Live
Well -- has a diversified, multi-channel business model and derives
revenue from product sales through company-owned retail stores,
domestic and international franchise activities, third party
contract manufacturing, e-commerce and corporate partnerships.
GNC's broad and deep product mix, which is focused on high-margin,
premium, value-added nutritional products, is sold under GNC
proprietary brands, including Mega Men®, Ultra Mega®, Total Lean™,
Pro Performance®, Pro Performance® AMP, Beyond Raw®, and under
nationally recognized third party brands.
Safe Harbor Statement:
Statements about the Company's future expectations and all other
statements in this press release other than historical facts, are
"forward-looking statements" within the meaning of Section 27A of
the Securities Act of 1933, Section 21E of the Securities Exchange
Act of 1934, and as that term is defined in the Private Securities
Litigation Reform Act of 1995. The Company intends that such
forward-looking statements be subject to the safe harbors created
thereby.
The above information contains information relating to the
Company that is based on the beliefs of the Company and/or its
management, as well as assumptions made by any information
currently available to the Company or its management. When used in
this document, the words "anticipate," "estimate," "expect,"
"intend," "plans," "projects," and similar expressions, as they
relate to the Company or its management, are intended to identify
forward-looking statements. Such statements reflect the current
view of the Company regarding future events and are subject to
certain risks, uncertainties and assumptions, including the risks
and uncertainties noted. Should one or more of these risks or
uncertainties materialize, or should underlying assumptions prove
to be incorrect, actual results may vary materially from those
described herein as anticipated, believed, estimated, expected,
intended or projected. In each instance, forward-looking
information should be considered in light of the accompanying
meaningful cautionary statements herein. Factors that could cause
results to differ include, but are not limited to, successful
performance of internal plans, the impact of competitive services
and pricing and general economic risks and uncertainties.
Contact: Investor Relations Taylor Capitol, Inc. Stephen Taylor
(973) 351-3868 STEPHTAYL9@AOL.COM www.TheStockAlerts.com
Allstar Health Brands (PK) (USOTC:ALST)
Historical Stock Chart
From Feb 2024 to Mar 2024
Allstar Health Brands (PK) (USOTC:ALST)
Historical Stock Chart
From Mar 2023 to Mar 2024